ALX ONCOLOGY HOLDINGS INC (ALXO) Total liabilities 2019–2022
ALX ONCOLOGY HOLDINGS INC (ALXO) total liabilities at each fiscal year-end, per SEC filings.
$43.0MFY2022 · since FY2019: $11.0M → $43.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $43.0M | +151.1% |
| FY2021 | $17.1M | +176.0% |
| FY2020 | $6.2M | -43.3% |
| FY2019 | $11.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Net marginALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Operating cash flowALXO Free cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Shareholders’ equityALXO overview →